#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infertility male Huntington's disease Monogenic diabetes Necrotising myositis Thrombotic thrombocytopenic purpura Pustular psoriasis Frostbite Demyelination Polymyositis B-cell type acute leukaemia Giant cell tumour of tendon sheath Neovascular age-related macular degeneration Glioblastoma Hepatitis B Scedosporium infection More trials…

    Learn about Rare Diseases

    Ocular melanoma – Diagnostics Hairy cell leukaemia – Life with Disease Undifferentiated sarcoma – Trials in Disease Pituitary-dependent Cushing’s syndrome – Diagnostics Haemophilia A without inhibitors – Basic Information Usher’s syndrome Myelodysplastic syndrome Retinitis pigmentosa – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Basic Information IgA nephropathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avacincaptad Pegol ZILUCOPLAN Phenol, Liquefied Rondaptivon Pegol Methoxyflurane Fingolimod Hydrochloride Azd2693 Sodium Vidutolimod Phenobarbital Mcla-129 SAR443820 Napabucasin Peppermint Oil Anv600 Lithium Carbonate Gemtuzumab Ozogamicin Anb032 Dactinomycin Lacosamide FOSMANOGEPIX More therapies…

    Learn about Your Condition

    Cirrhosis alcoholic Hodgkin's disease refractory Mucous membrane pemphigoid Small intestine carcinoma Pseudomonas infection Spinal cord injury cervical Paget's disease of the vulva Mitochondrial DNA depletion Peripheral artery angioplasty Colour blindness Rectal adenocarcinoma Ocular hypertension Lymphocytic leukaemia Intellectual disability Torticollis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Anti-CD19 CAR T-Cell Therapy for Patients with Refractory Systemic Autoimmune Diseases Using Levetiracetam, Fludarabine, and a Drug Combination

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Autoimmune disorder
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Levetiracetam
    • Cyclophosphamide
    Italy

  • Study of 64Cu-DOTATATE and 18F-FDG PET/CT imaging to predict disease progression in patients with neuroendocrine neoplasms

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma metastatic
    • Neuroendocrine tumour
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Copper (64Cu) Chloride
    • Fludeoxyglucose (18F)
    • Dotatate
    Denmark

  • Study on the Effectiveness of Fosfomycin, Cefixime, and Ciprofloxacin in Treating Acute Bacterial Prostatitis in Adult Men

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    Investigated Drugs:
    • Cefixime
    • Ciprofloxacin Hydrochloride
    • Fosfomycin
    Spain

  • Study on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Budesonide
    • Prednisone
    Belgium Croatia Greece Hungary Italy Poland

  • Study on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    Investigated Drugs:
    • Iptacopan Hydrochloride
    • Iptacopan
    Czechia France Germany Greece Italy The Netherlands +1

  • Study on Personalized Maintenance Therapy with Rituximab and Corticosteroids for Patients with Pemphigus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pemphigus
    Investigated Drugs:
    • Rituximab
    France
Previous Page
1 … 346 347 348 349 350 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!